Holen Sie sich die Stockscreener-App
231.10
0.50%
-1.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt THC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$232.26
Offen:
$231.16
24-Stunden-Volumen:
1.14M
Relative Volume:
1.15
Marktkapitalisierung:
$20.31B
Einnahmen:
$20.69B
Nettoeinkommen (Verlust:
$2.40B
KGV:
14.79
EPS:
15.6208
Netto-Cashflow:
$1.55B
1W Leistung:
+14.76%
1M Leistung:
+16.02%
6M Leistung:
+34.46%
1J Leistung:
+73.02%
1-Tages-Spanne:
$227.48
$235.50
1-Wochen-Bereich:
$186.50
$235.77
52-Wochen-Spanne:
$109.82
$235.77
Tenet Healthcare Corp Stock (THC) Company Profile
Firmenname
Tenet Healthcare Corp
Sektor
Branche
Telefon
469-893-2200
Adresse
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, UHS, FMS, ENSG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THC
Tenet Healthcare Corp
|
231.10 | 20.41B | 20.69B | 2.40B | 1.55B | 15.62 |
|
HCA
Hca Healthcare Inc
|
540.29 | 119.69B | 75.60B | 7.78B | 7.69B | 28.38 |
|
UHS
Universal Health Services Inc
|
234.81 | 14.62B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.44 | 14.18B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
213.34 | 12.46B | 4.11B | 239.98M | 193.10M | 4.12 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-02-26 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-03-29 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-10 | Hochstufung | UBS | Neutral → Buy |
| 2022-02-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Hochstufung | Truist | Hold → Buy |
| 2022-01-20 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Neutral |
| 2021-08-12 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Fortgesetzt | Citigroup | Buy |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-03 | Fortgesetzt | Goldman | Buy |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-15 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Fortgesetzt | Goldman | Neutral |
| 2019-02-26 | Bestätigt | BofA/Merrill | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-12-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-06-29 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Market Perform |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Bestätigt | Mizuho | Neutral |
| 2017-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Tenet Healthcare Corp Aktie (THC) Neueste Nachrichten
Tenet Healthcare Corporation $THC Position Trimmed by LSV Asset Management - MarketBeat
Rhumbline Advisers Has $48.46 Million Stake in Tenet Healthcare Corporation $THC - MarketBeat
ING Groep NV Sells 24,400 Shares of Tenet Healthcare Corporation $THC - MarketBeat
Barclays Raises Price Target for Tenet Healthcare (THC) to $257 - GuruFocus
Guggenheim raises Tenet Healthcare stock price target on strong 2026 guidance - Investing.com
THC: Guggenheim Raises Price Target for Tenet Healthcare | THC S - GuruFocus
Jefferies Raises Price Target for Tenet Healthcare (THC) to $265 - GuruFocus
UBS Raises Price Target for Tenet Healthcare (THC) to $288 | THC Stock News - GuruFocus
Tenet Healthcare Beats Q4 Earnings: But 2026 EBITDA Margin May Decline - Yahoo Finance
Tenet Healthcare stock price target raised to $250 from $225 at KeyBanc By Investing.com - Investing.com South Africa
THC: Keybanc Raises Price Target for Tenet Healthcare to $250 | - GuruFocus
Jefferies raises Tenet Healthcare stock price target to $265 on growth outlook - Investing.com
Tenet Healthcare Corporation (NYSE:THC) Q4 2025 Earnings Call Transcript - Insider Monkey
Tenet Healthcare stock price target raised to $250 from $225 at KeyBanc - Investing.com
THC Q4 Deep Dive: Tech-Driven Efficiency and Ambulatory Expansion Offset Exchange Headwinds - Finviz
Is It Too Late To Consider Tenet Healthcare (THC) After A 79% One Year Surge? - Yahoo Finance
Tenet Healthcare Q4 Earnings Call Highlights - Yahoo Finance
Tenet Healthcare Earnings Call Balances Growth and Risks - TipRanks
Tenet: Q4 Financial Results Overview - Bitget
Tenet Healthcare Corp (THC) Q4 2025 Earnings Call Highlights: St - GuruFocus
Tenet Looks Likely To Fend Off Many Upcoming Headwinds - Morningstar
Tenet Healthcare Expands with $1.9B Conifer Deal and Strong Profit Outlook - StocksToTrade
Tenet Healthcare stock price today: THC jumps 16% after Q4 results, 2026 outlook - TechStock²
Tenet Healthcare’s Strategic Deal With CommonSpirit Boosts Growth Forecast - StocksToTrade
Tenet Healthcare shares steady after strong Q4, upbeat 2026 outlook - AlphaStreet News
Tenet Healthcare stock hits all-time high of 222.83 USD - Investing.com
Tenet Healthcare Quarterly Profit Surges As Hospital, Surgery Demand Grows - Benzinga
Tenet Healthcare (NYSE:THC) Shares Up 11.8% Following Strong Earnings - MarketBeat
Tenet Healthcare Q4 2025 presentation: 13% EBITDA growth, balance sheet strengthens - Investing.com
Tenet Healthcare (THC) Q4 2025 Earnings Transcript - The Globe and Mail
Earnings call transcript: Tenet Healthcare Q4 2025 beats earnings expectations - Investing.com
Tenet Healthcare (NYSE:THC) Announces Quarterly Earnings Results - MarketBeat
Tenet Healthcare Q4 Earnings Summary & Key Takeaways - Benzinga
Tenet Healthcare reports Q4 adjusted EPS $4.70, consensus $4.05 - TipRanks
Tenet Healthcare (NYSE:THC) Surprises With Q4 CY2025 Sales - Finviz
Tenet Healthcare (THC) Exceeds Q4 Revenue Expectations - GuruFocus
Tenet Healthcare (THC) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Guggenheim Keeps Their Buy Rating on Tenet Healthcare (THC) - The Globe and Mail
Tenet Healthcare Corp (NYSE:THC) Reports Strong Q4 2025 Earnings Beat and Provides 2026 Outlook - ChartMill
Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook By Investing.com - Investing.com South Africa
Tenet Healthcare Corp. Profit Advances In Q4 - Nasdaq
Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook - Investing.com
Tenet: Q4 Earnings Snapshot - KTEN
Tenet Healthcare earnings beat by $0.68, revenue topped estimates - Investing.com
Tenet Healthcare Corporation Reports Strong Q4 and FY 2025 Results - TradingView
Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook - Yahoo Finance
Will Lower Patient Days Affect Tenet Healthcare's Q4 Earnings? - Finviz
Preview: Tenet Healthcare's Earnings - Benzinga
Tenet Healthcare (THC) Q4 Earnings: What To Expect - Finviz
Tenet Healthcare (THC) Valuation Check After Mixed Short Term Returns And Strong Multi Year Performance - Yahoo Finance
Tenet Healthcare (THC) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Finanzdaten der Tenet Healthcare Corp-Aktie (THC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):